Lansiaux A - Search Results

1

Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.

Leblond P, Boulet E, Bal-Mahieu C, Pillon A, Kruczynski A, Guilbaud N, Bailly C, Sarrazin T, Lartigau E, Lansiaux A, Meignan S. Leblond P, et al. Among authors: lansiaux a. Invest New Drugs. 2014 Oct;32(5):883-92. doi: 10.1007/s10637-014-0132-3. Epub 2014 Jul 11. Invest New Drugs. 2014. PMID: 25008900

2

Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.

Leblond P, Dewitte A, Le Tinier F, Bal-Mahieu C, Baroncini M, Sarrazin T, Lartigau E, Lansiaux A, Meignan S. Leblond P, et al. Among authors: lansiaux a. Anticancer Drugs. 2013 Sep;24(8):818-25. doi: 10.1097/CAD.0b013e328362edc5. Anticancer Drugs. 2013. PMID: 23728220

3

The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.

Mouawad F, Gros A, Rysman B, Bal-Mahieu C, Bertheau C, Horn S, Sarrazin T, Lartigau E, Chevalier D, Bailly C, Lansiaux A, Meignan S. Mouawad F, et al. Among authors: lansiaux a. Oral Oncol. 2014 Feb;50(2):113-9. doi: 10.1016/j.oraloncology.2013.11.003. Epub 2013 Nov 26. Oral Oncol. 2014. PMID: 24290982

4

[A symphony for the camptothecins].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 2003 Mar;90(3):239-45. Bull Cancer. 2003. PMID: 12801826 Free article. French.

5

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.

Barret JM, Kruczynski A, Vispé S, Annereau JP, Brel V, Guminski Y, Delcros JG, Lansiaux A, Guilbaud N, Imbert T, Bailly C. Barret JM, et al. Among authors: lansiaux a. Cancer Res. 2008 Dec 1;68(23):9845-53. doi: 10.1158/0008-5472.CAN-08-2748. Cancer Res. 2008. PMID: 19047165

6

Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials.

Penel N, Leblond P, Lansiaux A, Clisant S, Dansin E, Adenis A, Bonneterre J. Penel N, et al. Among authors: lansiaux a. Invest New Drugs. 2010 Dec;28(6):839-43. doi: 10.1007/s10637-009-9317-6. Epub 2009 Sep 16. Invest New Drugs. 2010. PMID: 19756372

7

[The inhibitor of integrins Cilengitide: a new active drug in neuro-oncology].

Leblond P, Meignan S, Le Tinier F, Bethe U, Lansiaux A. Leblond P, et al. Among authors: lansiaux a. Bull Cancer. 2011 Oct;98(9):1083-90. doi: 10.1684/bdc.2011.1429. Bull Cancer. 2011. PMID: 21914576 French.

8

[Perspectives on the oncologist pharmacopoeia].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 2003 Jan;90(1):25-30. Bull Cancer. 2003. PMID: 12609801 Free article. French.

9

[Ecteinascidin 743].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 1999 Feb;86(2):139-41. Bull Cancer. 1999. PMID: 10094523 Free article. Review. French. No abstract available.

10

[NB 506].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 1999 Mar;86(3):255-8. Bull Cancer. 1999. PMID: 10210758 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters